Tag Archives: Merck
Merck/Schering-Plough Merger Highlights (Update 1)
Merck and Schering-Plough’s CEOs are giving a run down of the benefits of the $41.1 billion merger, announced this morning, in a conference call with investors. Here are some of the highlights:
• Total price of the sale will be $41.1 billion or $23.6 per Schering share.
• This deal is structured as a reverse merger with [...]
Posted in Deals, Strategy Also tagged Deal, Johnson & Johnson, Merger, Remicade, Schering Plough, Vytorin 4 Comments
Schering-Plough to Merge with Merck for $41.1 Billion
Merck’s Richard T. Clark
Image via Wikipedia
Merck announced, a little over an hour ago, that it had signed an agreement with Schering-Plough’s board of directors to merge the two companies under the Merck name.
The stock and cash transaction is worth over $41 billion with Schering shareholders receiving $10.50 per share in cash and 0.5767 of a [...]
Pharma Layoffs Continue
It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines.
Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]
JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"
JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events Also tagged Art Levinson, conference, DNA, Erich Hunziker, Gene, Genentech, healthcare, JP Morgan, NME, Richard Clark, Roche, Ted Kennedy 1 Comment

Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger